Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helio S Sader

Showing results (411-420 of 420) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 420 results.
BMC Research Notes|June 9, 2012
Resistance trends in gram-negative bacteria: surveillance results from two Mexican hospitals, 2005-2010Rayo Morfin-Otero, Juan Carlos Tinoco-Favila, Helio S Sader, et al.
Infection and Drug Resistance|October 2, 2018
Multidrug-resistant <i>Pseudomonas aeruginosa</i> from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime-avibactamStan D Atkin, Shadaan Abid, Michael Foster, et al.
The Journal of Antimicrobial Chemotherapy|April 6, 2019
Pharmacokinetic/pharmacodynamic target attainment analyses to support intravenous and oral lefamulin dose selection for the treatment of patients with community-acquired bacterial pneumoniaSujata M Bhavnani, Li Zhang, Jeffrey P Hammel, et al.
The Pediatric Infectious Disease Journal|April 20, 2016
Evolution of Ceftaroline-Resistant Mrsa in a Child with Cystic Fibrosis Following Repeated Antibiotic ExposureChristopher R Cannavino, Rodrigo E Mendes, Helio S Sader, et al.
The Journal of Antimicrobial Chemotherapy|December 10, 2015
In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteriaAkinobu Ito, Naoki Kohira, Samuel K Bouchillon, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2009
Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006Helio S Sader, Paul D Fey, Ajit P Limaye, et al.
Open Forum Infectious Diseases|November 28, 2025
Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and <i>Pseudomonas aeruginosa</i>: Brief SummarySujata M Bhavnani, Jeffrey P Hammel, Nikolas J Onufrak, et al.
Open Forum Infectious Diseases|November 28, 2025
Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and <i>Pseudomonas aeruginosa</i>Sujata M Bhavnani, Jeffrey P Hammel, Nikolas J Onufrak, et al.
Journal of Clinical Microbiology|October 19, 2007
Detection of inducible clindamycin resistance in staphylococci by broth microdilution using erythromycin-clindamycin combination wellsJana M Swenson, William B Brasso, Mary Jane Ferraro, et al.
Journal of Clinical Microbiology|April 10, 2009
Correlation of cefoxitin MICs with the presence of mecA in Staphylococcus sppJana M Swenson, William B Brasso, Mary Jane Ferraro, et al.
Pageof 42

Showing results (411-420 of 420) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 420 results.
BMC Research Notes|June 9, 2012
Resistance trends in gram-negative bacteria: surveillance results from two Mexican hospitals, 2005-2010Rayo Morfin-Otero, Juan Carlos Tinoco-Favila, Helio S Sader, et al.
Infection and Drug Resistance|October 2, 2018
Multidrug-resistant <i>Pseudomonas aeruginosa</i> from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime-avibactamStan D Atkin, Shadaan Abid, Michael Foster, et al.
The Journal of Antimicrobial Chemotherapy|April 6, 2019
Pharmacokinetic/pharmacodynamic target attainment analyses to support intravenous and oral lefamulin dose selection for the treatment of patients with community-acquired bacterial pneumoniaSujata M Bhavnani, Li Zhang, Jeffrey P Hammel, et al.
The Pediatric Infectious Disease Journal|April 20, 2016
Evolution of Ceftaroline-Resistant Mrsa in a Child with Cystic Fibrosis Following Repeated Antibiotic ExposureChristopher R Cannavino, Rodrigo E Mendes, Helio S Sader, et al.
The Journal of Antimicrobial Chemotherapy|December 10, 2015
In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteriaAkinobu Ito, Naoki Kohira, Samuel K Bouchillon, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2009
Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006Helio S Sader, Paul D Fey, Ajit P Limaye, et al.
Open Forum Infectious Diseases|November 28, 2025
Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and <i>Pseudomonas aeruginosa</i>: Brief SummarySujata M Bhavnani, Jeffrey P Hammel, Nikolas J Onufrak, et al.
Open Forum Infectious Diseases|November 28, 2025
Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and <i>Pseudomonas aeruginosa</i>Sujata M Bhavnani, Jeffrey P Hammel, Nikolas J Onufrak, et al.
Journal of Clinical Microbiology|October 19, 2007
Detection of inducible clindamycin resistance in staphylococci by broth microdilution using erythromycin-clindamycin combination wellsJana M Swenson, William B Brasso, Mary Jane Ferraro, et al.
Journal of Clinical Microbiology|April 10, 2009
Correlation of cefoxitin MICs with the presence of mecA in Staphylococcus sppJana M Swenson, William B Brasso, Mary Jane Ferraro, et al.
Pageof 42